Forming a network of clinicians and scientists

The Nordic AML Group (NAMLG) aim to foster excellence in research and clinical care in acute myeloid leukemia (AML) in the Nordic countries, by forming an active network of clinicians and basic and translational scientists with deep interest and experience in the field.

Photo: NASA

POSTER SESSION AT THE NORDIC AML MEETING 2023

We invite attendees of the Nordic AML Meeting 2023 to contribute to the poster session of the conference. Poster presentations from previous conferences as well as interesting case reports are welcome.

Posters/case reports are to be submitted to: namlgewg@gmail.com. The deadline for submission is 1st of August.

Nordic AML Meeting

24-25 August, 2023, Bergen, Norway

Raddison Blu Bryggen, Bergen

See tenative program

Why a Nordic AML Group?

Recognizeable systems in Nordic countries, similar treatment traditions, one working market.

Unmet need to improve AML therapy through research and clinical trials.